<HashMap><database>biostudies-literature</database><scores/><additional><omics_type>Unknown</omics_type><volume>7(1)</volume><submitter>Chen L</submitter><pubmed_abstract>SARS-CoV-2, the culprit pathogen of COVID-19, elicits prominent immune responses and cytokine storms. Intracellular Cl&lt;sup>-&lt;/sup> is a crucial regulator of host defense, whereas the role of Cl&lt;sup>-&lt;/sup> signaling pathway in modulating pulmonary inflammation associated with SARS-CoV-2 infection remains unclear. By using human respiratory epithelial cell lines, primary cultured human airway epithelial cells, and murine models of viral structural protein stimulation and SARS-CoV-2 direct challenge, we demonstrated that SARS-CoV-2 nucleocapsid (N) protein could interact with Smad3, which downregulated cystic fibrosis transmembrane conductance regulator (CFTR) expression via microRNA-145. The intracellular Cl&lt;sup>-&lt;/sup> concentration ([Cl&lt;sup>-&lt;/sup>]&lt;sub>i&lt;/sub>) was raised, resulting in p</pubmed_abstract><journal>Signal transduction and targeted therapy</journal><pagination>255</pagination><full_dataset_link>https://www.ebi.ac.uk/biostudies/studies/S-EPMC9328007</full_dataset_link><repository>biostudies-literature</repository><pubmed_title>SARS-CoV-2 nucleocapsid protein triggers hyperinflammation via protein-protein interaction-mediated intracellular Cl&lt;sup>-&lt;/sup> accumulation in respiratory epithelium.</pubmed_title><pmcid>PMC9328007</pmcid><pubmed_authors>Huang ZX</pubmed_authors><pubmed_authors>Lun ZR</pubmed_authors><pubmed_authors>Huang ZY</pubmed_authors><pubmed_authors>Ye KN</pubmed_authors><pubmed_authors>Chen L</pubmed_authors><pubmed_authors>Lei TL</pubmed_authors><pubmed_authors>Bai X</pubmed_authors><pubmed_authors>Qu S</pubmed_authors><pubmed_authors>Guan WJ</pubmed_authors><pubmed_authors>Zhong NS</pubmed_authors><pubmed_authors>Zhang YL</pubmed_authors><pubmed_authors>Hou XC</pubmed_authors><pubmed_authors>Xu JB</pubmed_authors><pubmed_authors>Qiu ZE</pubmed_authors><pubmed_authors>Zhu YX</pubmed_authors><pubmed_authors>Zhou WL</pubmed_authors><pubmed_authors>Zhao J</pubmed_authors><pubmed_authors>Sun J</pubmed_authors></additional><is_claimable>false</is_claimable><name>SARS-CoV-2 nucleocapsid protein triggers hyperinflammation via protein-protein interaction-mediated intracellular Cl&lt;sup>-&lt;/sup> accumulation in respiratory epithelium.</name><description>SARS-CoV-2, the culprit pathogen of COVID-19, elicits prominent immune responses and cytokine storms. Intracellular Cl&lt;sup>-&lt;/sup> is a crucial regulator of host defense, whereas the role of Cl&lt;sup>-&lt;/sup> signaling pathway in modulating pulmonary inflammation associated with SARS-CoV-2 infection remains unclear. By using human respiratory epithelial cell lines, primary cultured human airway epithelial cells, and murine models of viral structural protein stimulation and SARS-CoV-2 direct challenge, we demonstrated that SARS-CoV-2 nucleocapsid (N) protein could interact with Smad3, which downregulated cystic fibrosis transmembrane conductance regulator (CFTR) expression via microRNA-145. The intracellular Cl&lt;sup>-&lt;/sup> concentration ([Cl&lt;sup>-&lt;/sup>]&lt;sub>i&lt;/sub>) was raised, resulting in p</description><dates><release>2022-01-01T00:00:00Z</release><publication>2022 Jul</publication><modification>2025-05-31T23:03:29.194Z</modification><creation>2022-08-03T07:05:23.275Z</creation></dates><accession>S-EPMC9328007</accession><cross_references><pubmed>35896532</pubmed><doi>10.1038/s41392-022-01048-1</doi></cross_references></HashMap>